- According to estimates from 24 analysts, Edwards Lifesciences Corporation stock's average price target has risen from $100.03 to $101.57, with forecasts ranging from $85 to $110 per share
- Based on the Jul. 23 closing price, the updated target implies approximately 21% potential upside
- Consensus rating remains at “Buy” across 30 covering analysts, with 23 Buys, 7 Holds and 0 Sells
Explore more price target data and ratings for Edwards Lifesciences Corporation on the , and track all previous and future analyst recommendations for Edwards Lifesciences Corporation in the dedicated .
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.